Unfortunately, this is a long-known issue in HIV care, as the at-risk population often perceives greater hurdles of stigma in their reason for seeking out preventive care.
In an interview with Contagion, Hugh Klein, PhD, study co-author of the PrEP Obstacles Scale, discussed solutions, both clinical and otherwise, in getting MSM adherence to PrEP.
None of the solutions are simple, nor untested thus far.
“As long they perceive stigma, they’re going to be looking for information in private,” Klein explained. “Part of the solution to the dilemma you’re prosing—which is a very real one—is how do you get people more familiar with PrEP, and people who use PrEP?”
Klein observed their research showed very few MSM are familiar with anyone who uses PrEP—but those who were had far few stigmas and false perceptions regarding its use and implication in HIV prevention.
This may mean greater PrEP acceptance may come via HIV community-based outreach and connections.
To stay informed on the latest in infectious disease news and developments, please sign upfor our weekly newsletter.
Contagion® is a fully integrated news resource covering all areas of infectious disease. Through our website, quarterly journal, email newsletters, social media outlets, and Outbreak Monitor we provide practitioners and specialists with disease-specific information designed to improve patient outcomes and assist with the identification, diagnosis, treatment, and prevention of infectious diseases. Our mission is to assure that the healthcare community and public have the knowledge to make more informed choices and have a positive impact on patient outcomes.
2 Clarke Drive
Cranbury, NJ 08512